| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | 2.687 | 16.949 | 25.364 | 26.460 | 25.470 | 28.824 | 13.626 | 26.373 |
| Total Income - EUR | - | - | 2.687 | 16.949 | 25.364 | 26.460 | 25.470 | 28.824 | 13.626 | 66.776 |
| Total Expenses - EUR | - | - | 2.911 | 18.957 | 38.803 | 37.522 | 34.041 | 34.164 | 24.162 | 56.586 |
| Gross Profit/Loss - EUR | - | - | -224 | -2.008 | -13.439 | -11.062 | -8.571 | -5.341 | -10.536 | 10.190 |
| Net Profit/Loss - EUR | - | - | -305 | -2.516 | -14.199 | -11.856 | -9.357 | -6.206 | -10.703 | 8.560 |
| Employees | - | - | 0 | 0 | 0 | 1 | 1 | 0 | 0 | 0 |
Check the financial reports for the company - Lya-Ozon Med Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | 4.922 | 7.891 | 56.368 | 50.902 | 45.969 | 44.219 | 36.611 | 8.633 |
| Current Assets | - | - | 648 | 5.203 | 4.812 | 3.341 | 10.966 | 3.500 | 3.207 | 25.016 |
| Inventories | - | - | 0 | 2.469 | 3.811 | 884 | 4.690 | 2.777 | 2.551 | 0 |
| Receivables | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash | - | - | 648 | 2.733 | 1.001 | 2.457 | 6.276 | 723 | 656 | 25.016 |
| Shareholders Funds | - | - | -261 | -2.773 | -16.918 | -28.454 | -37.180 | -43.501 | -56.605 | -45.880 |
| Social Capital | - | - | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | 5.831 | 15.867 | 78.098 | 84.682 | 94.115 | 91.221 | 96.424 | 79.529 |
| Income in Advance | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8696 - 8696" | |||||||||
| CAEN Financial Year |
8690
|
|||||||||
Comments - Lya-Ozon Med Srl